Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HAPLN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRSS30P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PTPN21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC34A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX6B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FXYD6-FXYD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APOE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCNXL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAGLA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSM14B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DRD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LILRB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on